NCT03174275 · OUTCOME

Correlation Between Measures of Clinical Response to Induction Chemotherapy and Long Term Outcomes (PFS and OS) and Compare Them to Pathologic Measures of Response (pCRR).

Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma · Source last updated 2026-02-23

This outcome was registered, but no numerical results were posted in the captured record.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: 8-12 weeks after the last dose of study treatment

What was measured

Pre-treatment specimens will be studied for predictive markers of treatment response. Paired pre- and post-treatment specimens will be compared to assess for changes in the tumor micro-environment.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

denom Units Selected: Participants
description: Pre-treatment specimens will be studied for predictive markers of treatment response. Paired pre- and post-treatment specimens will be compared to assess for changes in the tumor micro-environment.
reporting Status: NOT_POSTED
time Frame: 8-12 weeks after the last dose of study treatment
title: Correlation Between Measures of Clinical Response to Induction Chemotherapy and Long Term Outcomes (PFS and OS) and Compare Them to Pathologic Measures of Response (pCRR).
type: OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice